Abstract
DNA repair pathways maintain the integrity of the genome and thereby help prevent the onset of cancer, disease, and aging phenotypes [DNA Repair and Mutagenesis, ASM, Washington, DC]. As such, the critical requirement for DNA repair proteins and pathways in response to radiation and genotoxic chemotherapeutics implicates DNA repair proteins as prime targets for improving response to currently available anticancer regimens. Although defects in critical DNA repair pathways or proteins can predispose to cancer onset [FASEB J 26:2094–2104, 2012], such cancer-specific DNA repair defects offer novel approaches for tumor-selective therapy.
To effectively evaluate the functional role of a specific DNA repair protein with regard to cell survival, response to genotoxins, and genome stability, it has become standard practice to employ select genetic tools to alter expression of the gene of interest and/or reexpress a mutant transgene [Cancer Res 71:2308–2317, 2011; Mol Cancer Res 8:67–79, 2010; Neuro Oncol 13:471–486, 2011]. A useful approach to reduce or suppress a specific gene of interest in cells is RNA interference. Briefly, RNA interference is a posttranscriptional gene-silencing biological mechanism whereby RNA molecules inhibit gene expression either by translational suppression or by the targeted degradation of specific mRNA molecules. Once the gene of interest is suppressed in this manner and validated for gene expression loss, the resulting knockdown (KD) cells can be used for functional analysis to define the cellular impact of gene loss and provide a resource for evaluating mutants of the gene, such as somatic or germ-line mutations, for impact on function [PLoS Genet 8:e1003086, 2012]. Herein, we describe methods to modify human cells via RNA interference as well as methods to validate gene KD and some measures of cellular response to genotoxins to uncover functional DNA repair defects in the absence of the gene.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dykxhoorn DM, Novina CD, Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4:457–467
Mcmanus MT, Sharp PA (2002) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737–747
Paddison PJ, Hannon GJ (2002) RNA interference: the new somatic cell genetics? Cancer Cell 2:17–23
Schurmann N, Trabuco LG, Bender C et al (2013) Molecular dissection of human Argonaute proteins by DNA shuffling. Nat Struct Mol Biol 20:818–826
Caplen NJ, Parrish S, Imani F et al (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A 98:9742–9747
Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Izquierdo M (2005) Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 12:217–227
Ullu E, Djikeng A, Shi H et al (2002) RNA interference: advances and questions. Philos Trans R Soc Lond B Biol Sci 357:65–70
Svilar D, Dyavaiah M, Brown AR et al (2012) Alkylation sensitivity screens reveal a conserved cross-species functionome. Mol Cancer Res 10:1580–1596
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553
Paddison PJ, Caudy AA, Hannon GJ (2002) Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci U S A 99:1443–1448
Yu JY, Deruiter SL, Turner DL (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A 99:6047–6052
Javanbakht H, Halwani R, Cen S et al (2003) The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J Biol Chem 278:27644–27651
Tang J, Goellner EM, Wang XW et al (2010) Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage. Mol Cancer Res 8:67–79
Rubinson DA, Dillon CP, Kwiatkowski AV et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401–406
Goellner EM, Grimme B, Brown AR et al (2011) Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res 71:2308–2317
Mutamba JT, Svilar D, Prasongtanakij S et al (2011) XRCC1 and base excision repair balance in response to nitric oxide. DNA Repair (Amst) 10:1282–1293
Heid CA, Stevens J, Livak KJ et al (1996) Real time quantitative PCR. Genome Res 6:986–994
Semizarov D, Frost L, Sarthy A et al (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci U S A 100:6347–6352
Trivedi RN, Wang XH, Jelezcova E et al (2008) Human methyl purine DNA glycosylase and DNA polymerase ß expression collectively predict sensitivity to temozolomide. Mol Pharmacol 74:505–516
Tang JB, Svilar D, Trivedi RN et al (2011) N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. Neuro Oncol 13:471–486
Wang S, Sim TB, Kim YS et al (2004) Tools for target identification and validation. Curr Opin Chem Biol 8:371–377
Friedberg EC, Walker GC, Siede W et al (2006) DNA repair and mutagenesis, 2nd edn. ASM, Washington, DC
Sirbu BM, Cortez D (2013) DNA damage response: three levels of DNA repair regulation. Cold Spring Harb Perspect Biol 5:a012724
Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28:739–745
Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071–1078
Hassa PO, Haenni SS, Elser M et al (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70:789–829
Hottiger MO, Hassa PO, Luscher B et al (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35:208–219
Rulten SL, Fisher AE, Robert I et al (2011) PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol Cell 41:33–45
Almeida KH, Sobol RW (2007) A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair 6:695–711
Audebert M, Salles B, Calsou P (2004) Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 279:55117–55126
Audebert M, Salles B, Weinfeld M et al (2006) Involvement of polynucleotide kinase in a poly(ADP-ribose) polymerase-1-dependent DNA double-strand breaks rejoining pathway. J Mol Biol 356:257–265
Couto CA, Wang HY, Green JC et al (2011) PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks. J Cell Biol 194:367–375
Mansour WY, Rhein T, Dahm-Daphi J (2010) The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic Acids Res 38:6065–6077
Mitchell J, Smith GC, Curtin NJ (2009) Poly(ADP-Ribose) polymerase-1 and DNA-dependent protein kinase have equivalent roles in double strand break repair following ionizing radiation. Int J Radiat Oncol Biol Phys 75:1520–1527
Pears CJ, Couto CA, Wang HY et al (2012) The role of ADP-ribosylation in regulating DNA double-strand break repair. Cell Cycle 11:48–56
Robert I, Dantzer F, Reina-San-Martin B (2009) Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. J Exp Med 206:1047–1056
Wang M, Wu W, Wu W et al (2006) PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 34:6170–6182
Sobol RW (2012) Genome instability caused by a germline mutation in the human DNA repair gene POLB. PLoS Genet 8:e1003086
Alberts B (2009) Redefining cancer research. Science 325:1319
Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474–482
Kooistra SM, Helin K (2012) Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 13:297–311
Jones LJ, Gray M, Yue ST et al (2001) Sensitive determination of cell number using the CyQUANT cell proliferation assay. J Immunol Methods 254:85–98
Chi P, Allis CD, Wang GG (2010) Covalent histone modifications—miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10:457–469
Goellner EM, Svilar D, Almeida KH et al (2012) Targeting DNA polymerase ß for therapeutic intervention. Curr Mol Pharmacol 5:68–87
KeimLing M, Deniz M, Varga D et al (2012) The power of DNA double-strand break (DSB) repair testing to predict breast cancer susceptibility. FASEB J 26:2094–2104
Shamma A, Takegami Y, Miki T et al (2009) Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15:255–269
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354
Mccabe N, Turner NC, Lord CJ et al (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to Poly(ADP-Ribose) polymerase inhibition. Cancer Res 66:8109–8115
Ame JC, Fouquerel E, Gauthier LR et al (2009) Radiation-induced mitotic catastrophe in PARG-deficient cells. J Cell Sci 122:1990–2002
Jelezcova E, Trivedi RN, Wang XH et al (2010) Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage. Mutat Res 686:57–67
Acknowledgments
This work was supported by grants from the National Institute of Health (NIH) (CA148629, GM087798, and GM099213) to R.W.S. Support for the UPCI Lentiviral Facility was provided by the Cancer Center Support Grant from the National Institutes of Health (CA047904).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Fouquerel, E. et al. (2014). Use of RNA Interference to Study DNA Repair. In: Sierra, L., Gaivão, I. (eds) Genotoxicity and DNA Repair. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1068-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1068-7_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1067-0
Online ISBN: 978-1-4939-1068-7
eBook Packages: Springer Protocols